$SMTK
SmartKem, Inc.

2024 Q2 Form 10-Q Financial Statement

#000155837024008481 Filed on May 20, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $40.00K $0.00
YoY Change 400.0% -100.0%
Cost Of Revenue $32.00K $0.00
YoY Change 433.33% -100.0%
Gross Profit $8.000K $0.00
YoY Change 300.0%
Gross Profit Margin 20.0%
Selling, General & Admin $1.844M $1.362M
YoY Change 39.27% -4.95%
% of Gross Profit 23050.0%
Research & Development $1.158M $1.276M
YoY Change -7.88% -0.23%
% of Gross Profit 14475.0%
Depreciation & Amortization $62.00K $63.00K
YoY Change 58.97% 50.0%
% of Gross Profit 775.0%
Operating Expenses $3.021M $2.651M
YoY Change 19.03% -6.09%
Operating Profit -$2.777M -$2.449M
YoY Change 17.32% -4.11%
Interest Expense -$259.0K -$13.00K
YoY Change -144.81% -103.29%
% of Operating Profit
Other Income/Expense, Net -$321.0K $753.0K
YoY Change -194.41% 48.81%
Pretax Income -$3.098M -$1.696M
YoY Change 52.84% -17.19%
Income Tax $1.000K
% Of Pretax Income
Net Earnings -$3.099M -$1.696M
YoY Change 52.89% -15.2%
Net Earnings / Revenue -7747.5%
Basic Earnings Per Share -$0.98 -$0.62
Diluted Earnings Per Share -$0.98 -$3.21
COMMON SHARES
Basic Shares Outstanding 1.438M 1.355M
Diluted Shares Outstanding 3.157M 2.735M

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.351M $7.251M
YoY Change -68.41% 326.53%
Cash & Equivalents $4.400M $7.300M
Short-Term Investments
Other Short-Term Assets $910.0K $675.0K
YoY Change 14.18% -39.73%
Inventory
Prepaid Expenses
Receivables $0.00 $0.00
Other Receivables $1.243M $1.214M
Total Short-Term Assets $6.504M $9.140M
YoY Change -56.84% 113.65%
LONG-TERM ASSETS
Property, Plant & Equipment $327.0K $388.0K
YoY Change -41.4% -32.64%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $6.000K $6.000K
YoY Change 0.0% 0.0%
Total Long-Term Assets $559.0K $617.0K
YoY Change -42.9% -39.09%
TOTAL ASSETS
Total Short-Term Assets $6.504M $9.140M
Total Long-Term Assets $559.0K $617.0K
Total Assets $7.063M $9.757M
YoY Change -55.99% 84.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.121M $1.180M
YoY Change 64.85% 158.77%
Accrued Expenses $991.0K $1.032M
YoY Change -6.42% 26.32%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.459M $2.579M
YoY Change 40.35% 87.43%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $16.00K $623.0K
YoY Change -99.19% 231.38%
Total Long-Term Liabilities $16.00K $623.0K
YoY Change -99.19% 231.38%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.459M $2.579M
Total Long-Term Liabilities $16.00K $623.0K
Total Liabilities $2.475M $3.202M
YoY Change -33.49% 104.73%
SHAREHOLDERS EQUITY
Retained Earnings -$107.0M -$103.9M
YoY Change 18.0% 17.22%
Common Stock $0.00 $0.00
YoY Change -100.0% -100.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.588M $6.555M
YoY Change
Total Liabilities & Shareholders Equity $7.063M $9.757M
YoY Change -55.99% 84.41%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income -$3.099M -$1.696M
YoY Change 52.89% -15.2%
Depreciation, Depletion And Amortization $62.00K $63.00K
YoY Change 58.97% 50.0%
Cash From Operating Activities -$2.831M -$1.571M
YoY Change 344.43% -35.43%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.000K
YoY Change -99.98%
NET CHANGE
Cash From Operating Activities -2.831M -1.571M
Cash From Investing Activities
Cash From Financing Activities 3.000K
Net Change In Cash -2.828M -1.585M
YoY Change -123.52% -37.48%
FREE CASH FLOW
Cash From Operating Activities -$2.831M -$1.571M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001817760
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
0
CY2023Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
0
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
3592
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
13765
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1379750
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
889668
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
CY2023Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0286
CY2023Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0286
CY2023Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0286
CY2023Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0286
CY2023Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0286
CY2023Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0286
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
000-56181
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
SmartKem, Inc.
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
DE
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-1083654
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
Manchester Technology Centre, Hexagon Tower.
CY2024Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Delaunays Road
CY2024Q1 dei Entity Address Address Line3
EntityAddressAddressLine3
Blackley
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Manchester
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
M9 8GQ
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
X0
CY2024Q1 dei City Area Code
CityAreaCode
011-44-161
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
721-1514
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2024Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1438324
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7251000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8836000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
268000
CY2024Q1 smtk Research And Development Tax Credit
ResearchAndDevelopmentTaxCredit
807000
CY2023Q4 smtk Research And Development Tax Credit
ResearchAndDevelopmentTaxCredit
610000
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1082000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
811000
CY2024Q1 us-gaap Assets Current
AssetsCurrent
9140000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
10525000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
388000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
455000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
223000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
285000
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7000
CY2024Q1 us-gaap Assets
Assets
9757000
CY2023Q4 us-gaap Assets
Assets
11272000
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2038000
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1178000
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
174000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
230000
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
367000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
360000
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2579000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1768000
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
19000
CY2024Q1 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
619000
CY2023Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
1372000
CY2024Q1 us-gaap Liabilities
Liabilities
3202000
CY2023Q4 us-gaap Liabilities
Liabilities
3159000
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
3592
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
3592
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
13765
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
13765
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1379750
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1379750
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
889668
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
889668
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
112007000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
104757000
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1596000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1578000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-103856000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-95066000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
6555000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
8113000
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9757000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11272000
CY2023Q1 us-gaap Revenues
Revenues
16000
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
16000
CY2024Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
202000
CY2023Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
269000
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1276000
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1279000
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1362000
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1433000
CY2024Q1 smtk Foreign Currency Transaction Gain Loss Before Tax Operating
ForeignCurrencyTransactionGainLossBeforeTaxOperating
-13000
CY2023Q1 smtk Foreign Currency Transaction Gain Loss Before Tax Operating
ForeignCurrencyTransactionGainLossBeforeTaxOperating
-111000
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
2651000
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
2823000
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2449000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2554000
CY2024Q1 smtk Foreign Currency Transaction Gain Loss Before Tax Nonoperating
ForeignCurrencyTransactionGainLossBeforeTaxNonoperating
-6000
CY2023Q1 smtk Foreign Currency Transaction Gain Loss Before Tax Nonoperating
ForeignCurrencyTransactionGainLossBeforeTaxNonoperating
502000
CY2024Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-753000
CY2024Q1 us-gaap Interest Income Other
InterestIncomeOther
6000
CY2023Q1 us-gaap Interest Income Other
InterestIncomeOther
4000
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
753000
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
506000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-1696000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2048000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-1696000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2048000
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-18000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-456000
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1714000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-2504000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.62
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.45
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.21
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.45
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2.59
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2735375
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
835718
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2735375
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
835718
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
8113000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
107000
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
21000
CY2024Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
53000
CY2024Q1 smtk Deemed Dividend On Extinguishment Of Preferred Stock
DeemedDividendOnExtinguishmentOfPreferredStock
-25000
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-18000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-1696000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
6555000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
5883000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
293000
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
55000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-456000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2048000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
3727000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-1696000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-2048000
CY2024Q1 us-gaap Depreciation
Depreciation
63000
CY2023Q1 us-gaap Depreciation
Depreciation
42000
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
129000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
293000
CY2024Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
53000
CY2023Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
55000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
60000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
56000
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-19000
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
391000
CY2024Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-753000
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-267000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-29000
CY2024Q1 smtk Increase Decrease In Research And Development Tax Credit Receivable
IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable
202000
CY2023Q1 smtk Increase Decrease In Research And Development Tax Credit Receivable
IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable
211000
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
264000
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
340000
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
822000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
293000
CY2024Q1 smtk Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-69000
CY2023Q1 smtk Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-43000
CY2023Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-22000
CY2023Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-146000
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1571000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2433000
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-14000
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-102000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1585000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2535000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8836000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4235000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7251000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1700000
CY2024Q1 us-gaap Stock Issued1
StockIssued1
53000
CY2023Q1 us-gaap Stock Issued1
StockIssued1
55000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-1700000
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7300000
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7300000
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 17.85pt;"><span style="font-style:italic;font-weight:bold;">Management’s Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 0pt 17.85pt;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, including disclosure of contingent assets and liabilities, at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. The most significant estimates in the Company’s consolidated financial statements relate to the valuation of common stock, fair value of stock options and fair value of warrant liabilities. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. Due to the uncertainty of factors surrounding the estimates or judgments used in the preparation of the consolidated financial statements, actual results may materially vary from these estimates.</p>
CY2024Q1 us-gaap Prepaid Insurance
PrepaidInsurance
444000
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
274000
CY2024Q1 smtk Prepaid Research Grant Receivable
PrepaidResearchGrantReceivable
195000
CY2023Q4 smtk Prepaid Research Grant Receivable
PrepaidResearchGrantReceivable
160000
CY2024Q1 smtk Prepaid Facility Costs
PrepaidFacilityCosts
166000
CY2023Q4 smtk Prepaid Facility Costs
PrepaidFacilityCosts
101000
CY2024Q1 us-gaap Prepaid Taxes
PrepaidTaxes
176000
CY2023Q4 us-gaap Prepaid Taxes
PrepaidTaxes
104000
CY2024Q1 smtk Prepaid Software Licenses
PrepaidSoftwareLicenses
60000
CY2023Q4 smtk Prepaid Software Licenses
PrepaidSoftwareLicenses
24000
CY2024Q1 smtk Prepaid Professional Service Fees
PrepaidProfessionalServiceFees
5000
CY2023Q4 smtk Prepaid Professional Service Fees
PrepaidProfessionalServiceFees
68000
CY2024Q1 smtk Other Receivable And Other Prepaid Expenses
OtherReceivableAndOtherPrepaidExpenses
36000
CY2023Q4 smtk Other Receivable And Other Prepaid Expenses
OtherReceivableAndOtherPrepaidExpenses
80000
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1082000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
811000
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
69000
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
43000
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1700000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1716000
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1312000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1261000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
388000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
455000
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1180000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
355000
CY2024Q1 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
534000
CY2023Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
375000
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
182000
CY2024Q1 smtk Accrued Legal Fees Current
AccruedLegalFeesCurrent
90000
CY2024Q1 smtk Accrued Technical Costs Current
AccruedTechnicalCostsCurrent
79000
CY2023Q4 smtk Accrued Technical Costs Current
AccruedTechnicalCostsCurrent
91000
CY2024Q1 smtk Accrued Other Professional Service Fees Current
AccruedOtherProfessionalServiceFeesCurrent
57000
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
98000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
175000
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2038000
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1178000
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
65000
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
64000
CY2024Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
6000
CY2023Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
4000
CY2023Q1 us-gaap Variable Lease Cost
VariableLeaseCost
45000
CY2024Q1 us-gaap Lease Cost
LeaseCost
71000
CY2023Q1 us-gaap Lease Cost
LeaseCost
113000
CY2024Q1 us-gaap Lease Cost
LeaseCost
71000
CY2023Q1 us-gaap Lease Cost
LeaseCost
113000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
223000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
285000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
223000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
285000
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
174000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
230000
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
19000
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
178000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
249000
CY2024Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
0
CY2023Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
0
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y9M3D
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0628
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
167000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
19000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
186000
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
8000
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
178000
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q2 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
CY2024Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
12700000
CY2024Q1 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
1800000
smtk Warrants Issuance Costs Expensed
WarrantsIssuanceCostsExpensed
200000
CY2023Q2 smtk Warrants Issuance Costs Expensed
WarrantsIssuanceCostsExpensed
200000
CY2023Q2 smtk Term Of Restriction For Usage Of Cash From Operating Activities
TermOfRestrictionForUsageOfCashFromOperatingActivities
P3M
CY2023Q2 smtk Percentage Of Securities Sold In Subsequent Financing
PercentageOfSecuritiesSoldInSubsequentFinancing
0.40
CY2024Q1 smtk Common Stock Number Of Votes Per Share
CommonStockNumberOfVotesPerShare
1
CY2024Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
50000
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
70411
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
63.07
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y3M10D
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
33.98
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
491
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
70.00
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
69920
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
63.02
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y14D
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
33.98
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
46347
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
59.47
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y6M21D
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
78240
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
107000
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
293000
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
600000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-1696000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2048000
CY2024Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
7094000
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-8790000
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-2048000
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2735375
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
835718
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2735375
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
835718
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.62
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.45
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.21
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.45
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2.59
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3810693
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
169832
CY2024Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
61587
CY2024Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
1217723
CY2023Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
773773
CY2024Q1 smtk Weighted Average Pre Funded And Penny Warrants
WeightedAveragePreFundedAndPennyWarrants
1517652
CY2023Q1 smtk Weighted Average Pre Funded And Penny Warrants
WeightedAveragePreFundedAndPennyWarrants
61945
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2735375
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
835718
CY2024Q1 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
37000
CY2023Q1 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
40000
CY2024Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
619000
CY2024Q1 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
619000
CY2024Q1 smtk Extinguishment Of Preferred Stock Deemed Dividend Amount
ExtinguishmentOfPreferredStockDeemedDividendAmount
7094000
CY2024Q1 us-gaap Equity Fair Value Disclosure
EquityFairValueDisclosure
7094000
CY2023Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
1372000
CY2023Q4 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
1372000
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 smtk Rule10b51 Arr Modified Flag
Rule10b51ArrModifiedFlag
false
CY2024Q1 smtk Non Rule10b51 Arr Modified Flag
NonRule10b51ArrModifiedFlag
false

Files In Submission

Name View Source Status
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
smtk-20240331.xsd Edgar Link pending
smtk-20240331x10q.htm Edgar Link pending
smtk-20240331xex31d1.htm Edgar Link pending
smtk-20240331xex31d2.htm Edgar Link pending
smtk-20240331xex32d1.htm Edgar Link pending
smtk-20240331xex32d2.htm Edgar Link pending
smtk-20240331_lab.xml Edgar Link unprocessable
smtk-20240331_pre.xml Edgar Link unprocessable
smtk-20240331x10q_htm.xml Edgar Link completed
0001558370-24-008481-index-headers.html Edgar Link pending
0001558370-24-008481-index.html Edgar Link pending
0001558370-24-008481.txt Edgar Link pending
0001558370-24-008481-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
smtk-20240331_cal.xml Edgar Link unprocessable
smtk-20240331_def.xml Edgar Link unprocessable